文献速递肝病消化道肿瘤与早癌

5-羟色胺受体1D通过依赖和非依赖AKT的方式经FoxO6加重肝细胞癌进展

5-Hydroxytryptamine Receptor 1D Aggravates Hepatocellular Carcinoma Progression Through FoxO6 in AKT-Dependent and Independent Manners.
PubMed 文献 · Hepatology · 2019-03-10

研究显示5-HT1D在肝细胞癌组织和细胞系中表达显著上调,与不良临床病理特征相关,高表达预示总生存差和复发概率高。功能实验表明5-HT1D促进肝癌增殖、上皮间质转化和转移,机制上通过稳定PIK3R1激活PI3K/Akt/FoxO6通路,并以非Akt依赖方式直接转录激活FoxO6。

要点

  • 5-HT1D在肝细胞癌组织和细胞系中表达显著上调,与不良临床病理特征密切相关。
  • 5-HT1D高表达预示肝细胞癌患者总生存差和复发概率高。
  • 5-HT1D通过稳定PIK3R1激活PI3K/Akt/FoxO6通路,并以非Akt依赖方式直接转录激活FoxO6。

核心结论

  • 5-HT1D通过与PIK3R1相互作用激活PI3K/Akt/FoxO6通路,对肝细胞癌发挥强致癌作用,并提供潜在治疗靶点。

研究设计与样本

  • 研究为实验性研究,检测肝细胞癌组织与细胞系中5-HT1D表达,并进行功能与机制实验。

主要发现

  • 5-HT1D表达水平在肝细胞癌组织和细胞系中显著上调,且与不良临床病理特征密切相关。
  • 生存分析显示5-HT1D表达升高预示肝细胞癌患者总生存差和复发概率高。
  • 功能研究显示5-HT1D在体外和体内显著促进肝细胞癌增殖、上皮间质转化和转移。
  • 机制上5-HT1D通过抑制泛素介导的降解稳定PIK3R1,PIK3R1与5-HT1D相互作用经PI3K/Akt信号通路上调FoxO6。
  • FoxO6也可由5-HT1D以非Akt依赖方式直接转录激活,微小RNA-599为5-HT1D上游抑制性调控因子,5-HT1D经PI3K/Akt/cut样同源盒1轴减弱色氨酸羟化酶1表达。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Serotonin and its receptors have been shown to play critical regulatory roles in cancer biology. Nevertheless, the contributions of 5-hydroxytryptamine 1D (5-HT1D), an indispensable member of the serotonergic system, to hepatocellular carcinoma (HCC) remain unknown. The present study demonstrated that the 5-HT1D expression level was significantly up-regulated in HCC tissues and cell lines. The 5-HT1D expression level was closely correlated with unfavorable clinicopathological characteristics. Survival analyses show that elevated 5-HT1D expression level predicts poor overall survival and high recurrence probability in HCC patients. Functional studies revealed that 5-HT1D significantly promoted HCC proliferation, epithelial-mesenchymal transition, and metastasis in vitro and in vivo. Mechanistically, 5-HT1D could stabilize PIK3R1 by inhibiting its ubiquitin-mediated degradation. The interaction between 5-HT1D and phosphoinositide-3-kinase regulatory subunit 1 (PIK3R1) enhanced the expression of FoxO6 through the PI3K/Akt signaling pathway; FoxO6 could also be directly transcriptionally activated by 5-HT1D in an Akt-independent manner. MicroRNA-599 was found to be an upstream suppressive modulator of 5-HT1D. Additionally, 5-HT1D could attenuate tryptophan hydroxylase 1 expression through the PI3K/Akt/cut-like homeobox 1 axis in HCC. Conclusion: Herein, we uncovered the potent oncogenic effect of 5-HT1D on HCC by interacting with PIK3R1 to activate the PI3K/Akt/FoxO6 pathway, and provided a potential therapeutic target for HCC.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Zuo X, Chen Z, Cai J, et al. 5-Hydroxytryptamine Receptor 1D Aggravates Hepatocellular Carcinoma Progression Through FoxO6 in AKT-Dependent and Independent Manners. Hepatology. 2019. PMID: 30561038. doi:10.1002/hep.30430

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。